Μαρία Κάρλου

970 total citations
19 papers, 739 citations indexed

About

Μαρία Κάρλου is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Μαρία Κάρλου has authored 19 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Μαρία Κάρλου's work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Genetic factors in colorectal cancer (5 papers). Μαρία Κάρλου is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Genetic factors in colorectal cancer (5 papers). Μαρία Κάρλου collaborates with scholars based in Greece, United States and Spain. Μαρία Κάρλου's co-authors include Eleni Efstathiou, Vassiliki Tzelepi, Anh Hoang, Christopher J. Logothetis, Patricia Troncoso, Sijin Wen, Mark Titus, Robynne Ashe, James L. Mohler and Shi Ming Tu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Urology.

In The Last Decade

Μαρία Κάρλου

18 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Μαρία Κάρλου Greece 13 477 282 211 177 130 19 739
CL Arteaga United States 12 316 0.7× 429 1.5× 175 0.8× 544 3.1× 161 1.2× 27 946
Peter C. Haughney United States 13 350 0.7× 323 1.1× 86 0.4× 115 0.6× 87 0.7× 20 715
Shoichi Matsukuma Japan 17 434 0.9× 285 1.0× 142 0.7× 298 1.7× 107 0.8× 30 838
Òscar Reig Spain 13 303 0.6× 190 0.7× 153 0.7× 218 1.2× 66 0.5× 56 562
Tetsukan Woo Japan 19 374 0.8× 378 1.3× 223 1.1× 355 2.0× 62 0.5× 42 880
Barur Rajeshkumar United States 7 696 1.5× 349 1.2× 225 1.1× 93 0.5× 305 2.3× 11 923
Wendy Onstenk Netherlands 19 397 0.8× 257 0.9× 456 2.2× 455 2.6× 46 0.4× 25 813
Irene De Santo Italy 9 342 0.7× 169 0.6× 213 1.0× 394 2.2× 49 0.4× 13 692
John L. Silberstein United States 12 728 1.5× 314 1.1× 323 1.5× 413 2.3× 120 0.9× 16 1.0k
Adam Jendrisak United States 10 679 1.4× 255 0.9× 518 2.5× 510 2.9× 68 0.5× 32 988

Countries citing papers authored by Μαρία Κάρλου

Since Specialization
Citations

This map shows the geographic impact of Μαρία Κάρλου's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Μαρία Κάρλου with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Μαρία Κάρλου more than expected).

Fields of papers citing papers by Μαρία Κάρλου

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Μαρία Κάρλου. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Μαρία Κάρλου. The network helps show where Μαρία Κάρλου may publish in the future.

Co-authorship network of co-authors of Μαρία Κάρλου

This figure shows the co-authorship network connecting the top 25 collaborators of Μαρία Κάρλου. A scholar is included among the top collaborators of Μαρία Κάρλου based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Μαρία Κάρλου. Μαρία Κάρλου is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Efstathiou, Eleni, Mark Titus, Sijin Wen, et al.. (2014). Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer. European Urology. 67(1). 53–60. 185 indexed citations
2.
Levidou, Georgia, Angelica A. Saetta, Μαρία Κάρλου, et al.. (2012). ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World Journal of Surgical Oncology. 10(1). 47–47. 34 indexed citations
3.
Κάρλου, Μαρία, Jing‐Fang Lu, Guanglin Wu, et al.. (2012). Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b. The Prostate. 72(15). 1638–1647. 26 indexed citations
4.
Efstathiou, Eleni, Μαρία Κάρλου, Sijin Wen, et al.. (2012). Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. The Prostate. 73(2). 153–161. 17 indexed citations
5.
Korkolopoulou, Penelope, Georgia Levidou, Μαρία Κάρλου, et al.. (2012). A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3‐kinase/v‐akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. British Journal of Urology. 110(11c). E1237–48. 46 indexed citations
6.
Efstathiou, Eleni, Mark Titus, Dimitra Tsavachidou, et al.. (2012). Abstract 2696: Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100. Cancer Research. 72(8_Supplement). 2696–2696. 1 indexed citations
7.
Levidou, Georgia, Angelica A. Saetta, Μαρία Κάρλου, et al.. (2012). ERK/pERK expression, B-raf and K-ras mutations in colon adenocarcinomas: correlation with clinicopathological characteristics and expression of hMLH1 and hMSH2.. World Journal of Surgical Oncology. 10(1). 47–47. 3 indexed citations
8.
Titus, Mark, Dimitra Tsavachidou, Anh Hoang, et al.. (2011). MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report.. Journal of Clinical Oncology. 29(15_suppl). 4501–4501. 23 indexed citations
9.
Tzelepi, Vassiliki, Μαρία Κάρλου, Sijin Wen, et al.. (2011). Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling. Histopathology. 58(7). 1037–1047. 32 indexed citations
10.
Tzelepi, Vassiliki, Eleni Efstathiou, Sijin Wen, et al.. (2011). Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment. Journal of Clinical Oncology. 29(18). 2574–2581. 64 indexed citations
11.
Efstathiou, Eleni, Mark Titus, Dimitra Tsavachidou, et al.. (2011). Abstract LB-421: Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone. Cancer Research. 71(8_Supplement). LB–421.
12.
Efstathiou, Eleni, Mark Titus, Dimitra Tsavachidou, et al.. (2011). Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone. Journal of Clinical Oncology. 30(6). 637–643. 134 indexed citations
13.
Levidou, Georgia, Hariklia Gakiopoulou, Nikolaos Kavantzas, et al.. (2010). Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma. British Journal of Urology. 108(2b). E59–65. 30 indexed citations
14.
Κάρλου, Μαρία, Vassiliki Tzelepi, & Eleni Efstathiou. (2010). Therapeutic targeting of the prostate cancer microenvironment. Nature Reviews Urology. 7(9). 494–509. 91 indexed citations
15.
Levidou, Georgia, Angelica A. Saetta, Μαρία Κάρλου, et al.. (2010). D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance. Journal of Cancer Research and Clinical Oncology. 136(10). 1563–1571. 19 indexed citations
16.
Κάρλου, Μαρία, Angelica A. Saetta, Penelope Korkolopoulou, et al.. (2009). Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. Pathology. 41(4). 327–334. 21 indexed citations
17.
Saetta, Angelica A., et al.. (2007). Mutations of microsatellite instability target genes in sporadic basal cell carcinomas. Pathology - Research and Practice. 203(12). 849–855. 3 indexed citations
18.
Saetta, Angelica A., Penelope Korkolopoulou, Μαρία Κάρλου, et al.. (2007). TGF-βRIl, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder. Pathology. 39(4). 425–432. 2 indexed citations
19.
Saetta, Angelica A., Nikolaos V. Michalopoulos, Μαρία Κάρλου, et al.. (2006). Analysis of PRNP Gene Codon 129 Polymorphism in the Greek Population. European Journal of Epidemiology. 21(3). 211–215. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CL Arteaga Breakdown of academic impact, for papers by Peter C. Haughney Breakdown of academic impact, for papers by Shoichi Matsukuma Breakdown of academic impact, for papers by Òscar Reig Breakdown of academic impact, for papers by Tetsukan Woo Breakdown of academic impact, for papers by Barur Rajeshkumar Breakdown of academic impact, for papers by Wendy Onstenk Breakdown of academic impact, for papers by Irene De Santo Breakdown of academic impact, for papers by John L. Silberstein Breakdown of academic impact, for papers by Adam Jendrisak
Rankless by CCL
2026